The humoral immune response to BCG vaccination

The humoral immune response to BCG vaccination

Bacillus Calmette Guérin (BCG) is the only currently available vaccine against tuberculosis (TB), but it confers incomplete and variable protection against pulmonary TB in humans and bovine TB (bTB) in cattle. Insights into the immune response induced by BCG offer an underexploited opportunity to ga...

Full description

Bibliographic Details
Main Authors:	Tanner, R, Villarreal-Ramos, B, Vordermeier, H, McShane, H
Format:	Journal article
Published:	Frontiers Media 2019

Similar Items

The Humoral Immune Response to BCG Vaccination
by: Rachel Tanner, et al.
Published: (2019-06-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2017)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
by: Dean, G, et al.
Published: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
by: Villarreal-Ramos, B, et al.
Published: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
by: Villarreal-Ramos, B, et al.
Published: (2014)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
by: Biffar, L, et al.
Published: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
by: Dean, G, et al.
Published: (2014)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
by: Pepponi, I, et al.
Published: (2017)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
by: Vordermeier, H, et al.
Published: (2009)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
by: Harris, S, et al.
Published: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
by: Vordermeier, H, et al.
Published: (2011)

Understanding BCG is the key to improving it.
by: McShane, H
Published: (2013)

Revaccination with BCG: does it work?
by: McShane, H
Published: (2024)

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression
by: Pérez De Val, B, et al.
Published: (2013)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
by: Vordermeier, H, et al.
Published: (2011)

Editorial commentary: Understanding BCG is the key to improving it
by: McShane, H
Published: (2014)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Satti, I, et al.
Published: (2022)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Vaccination against tuberculosis: How can we better BCG?
by: Pitt, J, et al.
Published: (2013)

BCG vaccine-induced mucosal humoral immunity in human nasal associated lymphoid tissue
by: Talal M. Aljeraisi, et al.
Published: (2023-08-01)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Fletcher, H, et al.
Published: (2016)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Whelan, K, et al.
Published: (2009)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression.
by: Bernat Pérez de Val, et al.
Published: (2013-01-01)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
by: Fletcher, H, et al.
Published: (2016)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
by: Gillian S Dean, et al.
Published: (2015-01-01)

A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression
by: Perez de Val, B, et al.
Published: (2013)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Minassian, A, et al.
Published: (2011)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
by: Iman Satti, et al.
Published: (2022-11-01)

Invitro immune responses in children following BCG vaccination
by: Vijayalakshmi V, et al.
Published: (2006-01-01)

Persistence of the immune response induced by BCG vaccination
by: Blitz Rose, et al.
Published: (2008-01-01)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
by: Jorge A. Soto, et al.
Published: (2018-12-01)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
by: Dean, G, et al.
Published: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
by: Dean, G, et al.
Published: (2014)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Kathryn T Whelan, et al.
Published: (2009-06-01)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
by: Tanner, R, et al.
Published: (2016)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Helen A. Fletcher, et al.
Published: (2016-04-01)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
by: Mcshane, H
Published: (2008)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
by: Kathryn T. Whelan, et al.
Published: (2011-01-01)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
by: Smith, S, et al.
Published: (2010)